Patent ID: 9579325
Date: 2017-02-28
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method of treating TNF-α mediated inflammatory bowel disease in a patient in need of such treatment, comprising administering to the patient a therapeutically effective amount of a compound of Formula (II): or a physiologically acceptable salt thereof, wherein, R5 is substituted or unsubstituted aralkyl, substituted or unsubstituted cycloalkyl, or substituted or unsubstituted cycloalkylalkyl; R6 is —H or —NR13R14; R7 is substituted or unsubstituted phenyl; and R13 and R14 are each, independently, —H, a substituted or unsubstituted alkyl, a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted aryl, a substituted or unsubstituted aralkyl; or R13 and R14 together with the nitrogen to which they are attached are a heterocycloalkyl.